These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 29788839)
1. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation. Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839 [TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics of Phenobarbital in Neonates and Infants on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy. Thibault C; Massey SL; Abend NS; Naim MY; Zoraian A; Zuppa AF J Clin Pharmacol; 2021 Mar; 61(3):378-387. PubMed ID: 32960986 [TBL] [Abstract][Full Text] [Related]
3. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. Elliott ES; Buck ML Ann Pharmacother; 1999 Apr; 33(4):419-22. PubMed ID: 10332532 [TBL] [Abstract][Full Text] [Related]
4. Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures. Lee SM; Chung JY; Lee YM; Park MS; Namgung R; Park KI; Lee C Arch Dis Child; 2012 Jun; 97(6):569-72. PubMed ID: 22331680 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review. Yalcin N; Sürmelioğlu N; Allegaert K BMJ Paediatr Open; 2022 Nov; 6(1):. PubMed ID: 36437518 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update. Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343 [TBL] [Abstract][Full Text] [Related]
7. Rapid Increase in Clearance of Phenobarbital in Neonates on Extracorporeal Membrane Oxygenation: A Pilot Retrospective Population Pharmacokinetic Analysis. Michaličková D; Pokorná P; Tibboel D; Slanař O; Knibbe CAJ; Krekels EHJ Pediatr Crit Care Med; 2020 Sep; 21(9):e707-e715. PubMed ID: 32639476 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of phenobarbital in neonates. Touw DJ; Graafland O; Cranendonk A; Vermeulen RJ; van Weissenbruch MM Eur J Pharm Sci; 2000 Dec; 12(2):111-6. PubMed ID: 11102738 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy. Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863 [TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of IV Phenobarbital in Neonates After Congenital Heart Surgery. Thibault C; Massey SL; Naim MY; Abend NS; Zuppa AF Pediatr Crit Care Med; 2020 Aug; 21(8):e557-e565. PubMed ID: 32224827 [TBL] [Abstract][Full Text] [Related]
11. Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia. Šíma M; Pokorná P; Hartinger J; Slanař O J Clin Pharm Ther; 2018 Apr; 43(2):196-201. PubMed ID: 28940525 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. Hahn J; Choi JH; Chang MJ J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach. Marsot A; Brevaut-Malaty V; Vialet R; Boulamery A; Bruguerolle B; Simon N Fundam Clin Pharmacol; 2014 Aug; 28(4):465-71. PubMed ID: 23855753 [TBL] [Abstract][Full Text] [Related]
14. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Peters JW; Anderson BJ; Simons SH; Uges DR; Tibboel D Intensive Care Med; 2005 Feb; 31(2):257-63. PubMed ID: 15678314 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. Dodge WF; Jelliffe RW; Zwischenberger JB; Bellanger RA; Hokanson JA; Snodgrass WR Ther Drug Monit; 1994 Dec; 16(6):552-9. PubMed ID: 7878693 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies. Sharpe C; Yang DZ; Haas RH; Reiner GE; Lee L; Capparelli EV; Arch Dis Child; 2024 Sep; 109(10):854-860. PubMed ID: 38902005 [TBL] [Abstract][Full Text] [Related]
17. Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation. Völler S; Flint RB; Stolk LM; Degraeuwe PLJ; Simons SHP; Pokorna P; Burger DM; de Groot R; Tibboel D; Knibbe CAJ; Eur J Pharm Sci; 2017 Nov; 109S():S90-S97. PubMed ID: 28506869 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation. Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants. Yukawa E; Suematsu F; Yukawa M; Minemoto M J Clin Pharm Ther; 2005 Apr; 30(2):159-63. PubMed ID: 15811169 [TBL] [Abstract][Full Text] [Related]